chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Headache, Immunisation
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Oct2021 at 16:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Feb2021 at 16:00 (at the age of 58-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Mar2021 at 16:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. On 26Oct2021 at 00:00, the patient experienced extreme pain in right hip, arthritis type pain in shoulders, neck, back and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events experienced extreme pain in right hip, arthritis type pain in shoulders, neck, back and headache was resolved with sequelae on an unknown date in 2021. The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chest pain, Headache, Pain in extremity
Clinical narrative: Sore arm; Headache; Upset stomach; Chest pain; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 32030BD) via an unspecified route of administration in the left arm on 12Nov2021 at 11:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8841) via an unspecified route of administration in the left arm on 22Oct2021 at 11:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. On 13Nov2021 at 09:00, the patient experienced sore arm, headache, upset stomach and chest pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, headache, upset stomach and chest pain was resolved with sequelae on unknown date in Nov2021.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymph node pain, Lymphadenopathy, Migraine, Pain
Clinical narrative: Lymph node in my right arm pit swelled and ached; Lymph node in my right arm pit swelled and ached; Fever; Chills; Body aches; I had a migraine all day; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 320308BD) via an unspecified route of administration in the right arm on 12Nov2021 at 18:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Oct2021 at 18:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 13Nov2021 at 05:00, the day after, the patient experienced fever, chills, body aches. The patient had migraine all day. On 14Nov2021, 2 days later, the patient experienced lymph node in her right arm pit swelled and ached and still had for 2 additional days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the event fever, chills, body aches, migraine all day and lymph node in her right arm pit swelled and ached were not resolved at the time of this report.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Lymph node in my right arm pit swelled and ached; Lymph node in my right arm pit swelled and ached; Fever; Chills; Body aches; I had a migraine all day; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 320308BD) via an unspecified route of administration in the right arm on 12Nov2021 at 18:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Oct2021 at 18:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 13Nov2021 at 05:00, the day after, the patient experienced fever, chills, body aches. The patient had migraine all day. On 14Nov2021, 2 days later, the patient experienced lymph node in her right arm pit swelled and ached and still had for 2 additional days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the event fever, chills, body aches, migraine all day and lymph node in her right arm pit swelled and ached were not resolved at the time of this report.
Sex: F
Vaccine: COVID19
Symptoms: Deafness, Insomnia, Tinnitus
Clinical narrative: Hearing loss; ringing in the ears; Severe insomnia; This is a spontaneous report from a contactable consumer. This female consumer (patient) reported for herself that:  A female of unspecified age received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via unspecified route of administration on unspecified date as dose 2, single for covid 19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included dose 1 of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported) via unspecified route of administration as dose 1, single for covid 19 immunization. Patient had no other health issues. It is not related to a study or programme. Patient reported that since her second dose of the Pfizer Covid 19 Vaccine she had experienced severe insomnia, hearing loss and ringing in the ears. Reporter seriousness for events were unspecified. Investigation not reported. The outcome of events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Immunisation, Migraine
Clinical narrative: Migraine headache the following day; Dose received: 3; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN (reported as 3203080)) via an unspecified route of administration in the left arm on 09Nov2021 at 12:30 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Mar2021 at 12:00 (at the age of 73-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 12Apr2021 at 12:00 (at the age of 73-years-old); both as single dose for COVID-19 immunisation. The patient experienced migraine headache the following day, on 10Nov2021 at 06:00. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event which included rest. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event migraine headache the following day was resolved on an unknown date in Nov2021. The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Muscle fatigue, Pruritus, Pyrexia
Clinical narrative: Tired; Muscle fatigue; Skin itched and it felt like something was biting me; It felt like something was biting me; Sore arm at site of injection; Feverish the night of the injection; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2589) via an unspecified route of administration in the left arm on 12Nov2021 at 11:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12Nov2021 at 14:00, the patient experienced sore arm at site of injection, was tired, had muscle fatigue, skin itched and it felt like something was biting her and felt feverish the night of the injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm at site of injection, tired, muscle fatigue, skin itched and it felt like something was biting her, feverish the night of the injection was resolved on an unknown date in Nov2021.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Tired; Muscle fatigue; Skin itched and it felt like something was biting me; It felt like something was biting me; Sore arm at site of injection; Feverish the night of the injection; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2589) via an unspecified route of administration in the left arm on 12Nov2021 at 11:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12Nov2021 at 14:00, the patient experienced sore arm at site of injection, was tired, had muscle fatigue, skin itched and it felt like something was biting her and felt feverish the night of the injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm at site of injection, tired, muscle fatigue, skin itched and it felt like something was biting her, feverish the night of the injection was resolved on an unknown date in Nov2021.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Gout, Hypersensitivity, Inflammation, Pain
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Sep2021 at 12:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included gout, hay fever and known allergies to dust, but nothing specific. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Concomitant medications were not reported. On 01Sep2021 at 13:00, the patient experienced left arm pain, extreme sinus and allergies issue, gout and inflammation issues greatly increased, lack of energy and body pain. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 18Sep2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was negative. The clinical outcome of the events left arm pain, extreme sinus and allergies issue, gout and inflammation issues greatly increased, lack of energy and body pain was not resolved at the time of this report. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8839) via an unspecified route of administration in the left arm on 21Sep2021 at 14:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test, Sinusitis
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Sep2021 at 12:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included gout, hay fever and known allergies to dust, but nothing specific. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Concomitant medications were not reported. On 01Sep2021 at 13:00, the patient experienced left arm pain, extreme sinus and allergies issue, gout and inflammation issues greatly increased, lack of energy and body pain. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 18Sep2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was negative. The clinical outcome of the events left arm pain, extreme sinus and allergies issue, gout and inflammation issues greatly increased, lack of energy and body pain was not resolved at the time of this report. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8839) via an unspecified route of administration in the left arm on 21Sep2021 at 14:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic spontaneous urticaria, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 28Apr2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had unspecified allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. On 29Aug2021, the patient developed chronic spontaneous urticaria. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had been tested for COVID-19. On 02Nov2021, the patient underwent PCR test (nasal swab) and the result was negative. No therapeutic measures were taken as a result of event. The clinical outcome of the event chronic spontaneous urticaria was not resolved at the time of this report.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Electric shock sensation, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FH8020) via an unspecified route of administration in the left arm on 03Nov2021 at 13:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to walnuts and pecans. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included multivitamins (one a day) (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2290) via an unspecified route of administration in the left arm on 13Oct2021 at 13:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. On 04Nov2021 at 08:00, the patient experienced burning sensations in her joints hands, wrists, ankles and knees, traveling bone pain, bones in hands and wrists hurt and electricity-like nerve zaps in muscles and joints. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had been tested for COVID-19. On 05Nov2021, the patient underwent BinaxNOW (nasal swab) test and the result was negative. No therapeutic measures were taken as a result of the events. The clinical outcome of the events burning sensations in the joints hands, wrists, ankles and knees, traveling bone pain, bones in hands and wrists hurt and electricity-like nerve zaps in muscles and joints was not resolved at the time of this report.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: I tested positive for COVID 19 on 15Nov2021; I tested positive for COVID 19 on 15Nov2021; This is a spontaneous report from a contactable consumer (patient). A 50-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: EL3248, Expiry Date: Not Reported) via an unspecified route of administration, administered in Right Arm on 22Mar2021 (at the age of 50-year-old) at 14:00 as dose 2, single and received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: EL3248, Expiry Date: Not Reported) via an unspecified route of administration, administered in Left Arm on 01Mar2021 at (at the age of 50-year-old) at 14:00 as dose 1, single both doses for covid-19 immunization. Medical history included Low thyroid. Concomitant medication included levothyroxine sodium (SYNTHROID) 50ug taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine in four weeks of vaccination. The patient was not infected with covid prior vaccination. On 13Nov2021, the patient experienced covid-19 infection. The patient stated that the patient tested positive for COVID-19 on 15Nov2021.The patient did not receive any treatment for the reported event. The patient tested positive post vaccination. The patient underwent lab tests and procedures which included sars-cov-2 test (Covid test type post vaccination=Nasal Swab): positive on 13Nov2021. The outcome of the event was not recovered.   No follow-up attempts are needed. No further information is expected
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure, Vaccination site pain
Clinical narrative: I tested positive for COVID 19 on 15Nov2021; I tested positive for COVID 19 on 15Nov2021; This is a spontaneous report from a contactable consumer (patient). A 50-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: EL3248, Expiry Date: Not Reported) via an unspecified route of administration, administered in Right Arm on 22Mar2021 (at the age of 50-year-old) at 14:00 as dose 2, single and received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: EL3248, Expiry Date: Not Reported) via an unspecified route of administration, administered in Left Arm on 01Mar2021 at (at the age of 50-year-old) at 14:00 as dose 1, single both doses for covid-19 immunization. Medical history included Low thyroid. Concomitant medication included levothyroxine sodium (SYNTHROID) 50ug taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine in four weeks of vaccination. The patient was not infected with covid prior vaccination. On 13Nov2021, the patient experienced covid-19 infection. The patient stated that the patient tested positive for COVID-19 on 15Nov2021.The patient did not receive any treatment for the reported event. The patient tested positive post vaccination. The patient underwent lab tests and procedures which included sars-cov-2 test (Covid test type post vaccination=Nasal Swab): positive on 13Nov2021. The outcome of the event was not recovered.   No follow-up attempts are needed. No further information is expected
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Immunisation, Nausea
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 24-year-old male patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an intramuscular route of administration in the left arm on 15Nov2021 at 00:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an intramuscular route of administration in the left arm on 28Jan2021 (at the age of 24-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8841) via an intramuscular route of administration in the left arm on 18Feb2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On 15Nov2021, the patient experienced headache, tiredness, fever, chills, nausea and pain and soreness at injection site. The events headache, tiredness, fever, chills, nausea and pain and soreness at injection site did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events headache, tiredness, fever, chills, nausea and pain and soreness at injection site. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, tiredness, fever, chills, nausea and pain and soreness at injection site was resolving at the time of report. No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 24-year-old male patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an intramuscular route of administration in the left arm on 15Nov2021 at 00:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an intramuscular route of administration in the left arm on 28Jan2021 (at the age of 24-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8841) via an intramuscular route of administration in the left arm on 18Feb2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On 15Nov2021, the patient experienced headache, tiredness, fever, chills, nausea and pain and soreness at injection site. The events headache, tiredness, fever, chills, nausea and pain and soreness at injection site did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events headache, tiredness, fever, chills, nausea and pain and soreness at injection site. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, tiredness, fever, chills, nausea and pain and soreness at injection site was resolving at the time of report. No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Nausea, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 13Nov2021 at 14:45 (at the age of 63-years-old) as 30 mcg/0.3 ml single dose for COVID-19 immunisation. Medical history included asthma, arthritis, heart murmur and known allergies to latex, sulfa drugs and seasonal allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cannabidiol (CBD), gummies (MANUFACTURER UNKNOWN), cyanocobalamin (B12), probiotics (MANUFACTURER UNKNOWN), curcuma longa rhizome (TURMERIC), calcium (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date and unknown if ongoing. The patient received steroid shot (MANUFACTURER UNKNOWN) in the hip on 01Nov2021, within four weeks prior to the COVID-19 vaccine. On 14Nov2021 at 00:00, the patient experienced tired, chills, nausea, weak, (took shot in left arm) pain in right arm and slight wheezing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events tired, chills, nausea, weak, (took shot in left arm) pain in right arm and slight wheezing was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 13Nov2021 at 14:45 (at the age of 63-years-old) as 30 mcg/0.3 ml single dose for COVID-19 immunisation. Medical history included asthma, arthritis, heart murmur and known allergies to latex, sulfa drugs and seasonal allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cannabidiol (CBD), gummies (MANUFACTURER UNKNOWN), cyanocobalamin (B12), probiotics (MANUFACTURER UNKNOWN), curcuma longa rhizome (TURMERIC), calcium (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date and unknown if ongoing. The patient received steroid shot (MANUFACTURER UNKNOWN) in the hip on 01Nov2021, within four weeks prior to the COVID-19 vaccine. On 14Nov2021 at 00:00, the patient experienced tired, chills, nausea, weak, (took shot in left arm) pain in right arm and slight wheezing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events tired, chills, nausea, weak, (took shot in left arm) pain in right arm and slight wheezing was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Immunisation, Vaccination site pain
Clinical narrative: This is a spontaneous report from a contactable consumer (pfizer colleague), the patient. A 40-year-old non-pregnant female patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8841) via intramuscular route of administration in the left arm on 15Nov2021 at 10:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included salbutamol (ALBUTEROL) and budesonide, formoterol fumarate (SYMBICORT); both for unknown indication from unknown date and unknown if ongoing. The patient did not receive other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E23247) via an intramuscular route of administration on 10Mar2021 (at the age of 39-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an intramuscular route of administration on 31Mar2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. On 15Nov2021 at 18:00, the patient experienced soreness at the injection site. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of event. The clinical outcome of the event soreness at the injection site was resolving at the time of this report.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Migraine, Nausea, Sensory loss
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2590) via an unspecified route of administration in the left arm on 09Nov2021 at 12:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any other medications within two weeks of vaccination. The patient previously took codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 09Nov2021 at 13:00, the patient experienced severe migraines, nausea, neurological problems - numbness and loss of sensation in hands- intermittent but severe when it occurred. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe migraines, nausea, neurological problems - numbness and loss of sensation in hands- intermittent but severe when it occurs were not resolved at the time of this report.
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first and second doses of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Numbers: UNKNOWN) via unspecified routes of administration in the left arm on unknown dates for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown dates, the patient had a migraine after the first and the second doses. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event which included treatment with an unspecified medication. The clinical outcome of the event migraine after the first and the second shots was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. Sender's Comments: Linked Report(s) : -PFIZER INC-202101555991 similar report from same reporter.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Nov2021 at 14:45 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. Concomitant medications included pravastatin (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN 81), "D3" and "B"; all taken for unknown indications from an unknown date and unknown if ongoing. On 14Nov2021 at 00:00, 7 days after vaccine, the patient had been losing a lot of hair and just kept falling out. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event she had been losing a lot of hair and just kept falling out was not resolved at the time of this report.The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Immunisation, Lip swelling
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8841) via an unspecified route of administration in the left arm on 04Oct2021 at 11:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis (MS), Grave's disease, high blood pressure and bee sting allergy. The patient took unspecified concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccines within four weeks prior to the vaccination which included first dose of influenza vaccine (MANUFACTURER UNKNOWN) (reported as flu) via an unspecified route of administration in the arm on 28Sep2021 for immunisation. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM6202) via an unspecified route of administration in the left arm on 02Mar2021 at 13:00 (at the age of 58-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 10:15 (at the age of 58-years-old); both as single doses for COVID-19 immunisation. On 09Oct2021 at 06:00, five days after the COVID-19 booster, the patient woke up with extremely swollen lips. She never had that happen before. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event which included application of ice and paraffin soft (VASELINE) and the swelling subsided slowly over about 24 hours. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extremely swollen lips was resolved on an unknown date in 2021.
Sex: M
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: This is a spontaneous report from a contactable consumer or other non hcp (patient) from a Pfizer-sponsored program Support. A male patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration, administered on 23Feb2021 as DOSE 2, SINGLE for covid-19 immunisation. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration, administered on unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the reporter reported that, received 2nd dose 4 days ago, he was prescribed amoxicillin today for a sinus infection, which is already 3 weeks, asking will it affect the vaccine. The patient received treatment for the event. The outcome for the event was unknown. No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Cystitis
Clinical narrative: chronic bladder infection; This is a spontaneous report from a contactable consumer (patient). A 82-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EN6203 and expiry date was not reported), via an unspecified route of administration, on 23Feb2021 at 09:15 AM (age at vaccination: 82-yeats-old), as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced chronic bladder infection. On 01Mar2021, the patient started with the treatment Cephalexin 250mg tablet, twice a day, for 30 days for the event. The Patient was scheduled to receive her second COVID-19 Vaccine on 16Mar2021. She asked if it was Ok for her to get the second COVID-19 Vaccine if she was taking the Cephalexin antibiotic. Outcome of the event was unknown. No follow-up attempts are possible, no further information are expected.
Sex: F
Vaccine: COVID19
Symptoms: Cystitis
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 88-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 06Mar2021 as dose 1, single for covid-19 immunisation. Patient has a history of bladder infection due to Stent placement between kidneys and bladder. The patient's concomitant medications were not reported. The patient previously took coumadin. On an unspecified date, after the first vaccination the patient experienced bladder infection. Patient received first dose of the Pfizer Covid vaccine on 06Mar2021 and was scheduled to receive the second dose on 27Mar2021 was asking currently taking Keflex (treatment), will it affect her taking the 2nd dose of the vaccine. Patient states that Bactrim cannot be given to people who take Coumadin as it raises INR. The outcome of event was reported as unknown.No follow up attempts are possible. Information about lot/batch number cannot been obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Eye pain, Feeling cold, Feeling hot
Clinical narrative: Not feeling tired but feel winded; My head is hot, like very hot; my body is shivering from being so cold; my body is shivering from being so cold; feel nauseated; my eyes are sore; my entire body is just ache; My fingers are turning ice white and so are my toes; This is a spontaneous report from a contactable consumer (patient). A 29-years-old non-pregnant female patient received BNT162B2 (BNT162B2, Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in arm right on 11May2021 at 11:45 as DOSE 2, SINGLE (at the age of 29-year-old) for covid-19 immunisation. Medical history included anxiety from an unknown date and unknown if ongoing (anxiety meds). Historical vaccine included first dose of BNT162B2 (BNT162B2, Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in arm right on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation and experienced chills. Prior vaccination, the patient had no covid and not tested covid post vaccination. The patient no other vaccine in four weeks. Concomitant medication included unspecified medication for anxiety and paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. On 11May2021 20:30, the patient experienced not feeling tired but feel winded, head was hot like very hot but my body was shivering from being so cold even though wearing layers and under a blanket. The patient felt nauseated, my eyes are sore, my entire body was just ache. The patient understand aches would come but was not this cold the first time. Just chills from what I can remember and sore arm. The patient's fingers are turning ice white and so are my toes. The patient had not received treatment for the events. On an unspecified date, outcome of the events was recovering. No follow-up attempts are needed. Information on Lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Skin discolouration
Clinical narrative: Not feeling tired but feel winded; My head is hot, like very hot; my body is shivering from being so cold; my body is shivering from being so cold; feel nauseated; my eyes are sore; my entire body is just ache; My fingers are turning ice white and so are my toes; This is a spontaneous report from a contactable consumer (patient). A 29-years-old non-pregnant female patient received BNT162B2 (BNT162B2, Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in arm right on 11May2021 at 11:45 as DOSE 2, SINGLE (at the age of 29-year-old) for covid-19 immunisation. Medical history included anxiety from an unknown date and unknown if ongoing (anxiety meds). Historical vaccine included first dose of BNT162B2 (BNT162B2, Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in arm right on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation and experienced chills. Prior vaccination, the patient had no covid and not tested covid post vaccination. The patient no other vaccine in four weeks. Concomitant medication included unspecified medication for anxiety and paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. On 11May2021 20:30, the patient experienced not feeling tired but feel winded, head was hot like very hot but my body was shivering from being so cold even though wearing layers and under a blanket. The patient felt nauseated, my eyes are sore, my entire body was just ache. The patient understand aches would come but was not this cold the first time. Just chills from what I can remember and sore arm. The patient's fingers are turning ice white and so are my toes. The patient had not received treatment for the events. On an unspecified date, outcome of the events was recovering. No follow-up attempts are needed. Information on Lot/batch number cannot be obtained.